Glenmede Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $21.1M | Sell |
|
|||||
|
2024
Q4 | $22.8M | Sell |
|
|||||
|
2024
Q3 | $30.9M | Sell |
|
|||||
|
2024
Q2 | $30.7M | Buy |
|
|||||
|
2024
Q1 | $30M | Sell |
|
|||||
|
2023
Q4 | $39.2M | Sell |
|
|||||
|
2023
Q3 | $52.9M | Sell |
|
|||||
|
2023
Q2 | $87.2M | Sell |
|
|||||
|
2023
Q1 | $87.2M | Sell |
|
|||||
|
2022
Q4 | $119M | Buy |
|
|||||
|
2022
Q3 | $99M | Sell |
|
|||||
|
2022
Q2 | $140M | Buy |
|
|||||
|
2022
Q1 | $137M | Buy |
|
|||||
|
2021
Q4 | $142M | Buy |
|
|||||
|
2021
Q3 | $102M | Sell |
|
|||||
|
2021
Q2 | $95.1M | Sell |
|
|||||
|
2021
Q1 | $97.9M | Sell |
|
|||||
|
2020
Q4 | $128M | Buy |
|
|||||
|
2020
Q3 | $115M | Buy |
|
|||||
|
2020
Q2 | $94.4M | Sell |
|
|||||
|
2020
Q1 | $132M | Hold |
|
|||||
|
2019
Q4 | $132M | Buy |
|
|||||
|
2019
Q3 | $98.5K | Sell |
|
|||||
|
2019
Q2 | $195K | Buy |
|
|||||
|
2019
Q1 | $168K | Sell |
|
|||||
|
2018
Q4 | $223K | Sell |
|
|||||
|
2018
Q3 | $227M | Buy |
|
|||||
|
2018
Q2 | $120M | Buy |
|
|||||
|
2018
Q1 | $114M | Hold |
|
|||||
|
2017
Q4 | $114M | Buy |
|
|||||
|
2017
Q3 | $81.3M | Sell |
|
|||||
|
2017
Q2 | $111M | Hold |
|
|||||
|
2017
Q1 | $111M | Sell |
|
|||||
|
2016
Q4 | $107M | Buy |
|
|||||
|
2016
Q3 | $108M | Sell |
|
|||||
|
2016
Q2 | $114M | Buy |
|
|||||
|
2016
Q1 | $87.4M | Buy |
|
|||||
|
2015
Q4 | $89.8M | Buy |
|
|||||
|
2015
Q3 | $86.9M | Buy |
|
|||||
|
2015
Q2 | $85.1M | Sell |
|
|||||
|
2015
Q1 | $91.3M | Buy |
|
|||||
|
2014
Q4 | $75.3M | Buy |
|
|||||
|
2014
Q3 | $69.7M | Buy |
|
|||||
|
2014
Q2 | $65.5M | Sell |
|
|||||
|
2014
Q1 | $71M | Buy |
|
|||||
|
2013
Q4 | $67.2M | Buy |
|
|||||
|
2013
Q3 | $58.8M | Buy |
|
|||||
|
2013
Q2 | $57.1M | Buy |
|